Every SEC Form 3/4/5 on record for this filer (CIK 1433982) — 10 issuers, 38 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | Director | 2016-01-06 → 2026-01-06 | 13 | −$2M |
| NXGL | NEXGEL, INC. | Director | 2022-01-03 → 2025-06-27 | 8 | $106,626 |
| SNGX | SOLIGENIX, INC. | Director | 2015-12-23 → 2025-06-20 | 15 | $16,065 |
| NEXI | NexImmune, Inc. | Executive VP of Research & Dev · lapsed | 2021-02-11 → 2022-04-07 | 4 | $99,994 |
| BSGM | BioSig Technologies, Inc. | Director · lapsed | 2015-07-20 → 2020-07-15 | 8 | $10,490 |
| SRNE | Sorrento Therapeutics, Inc. | See Remarks · lapsed | 2016-11-15 → 2018-11-27 | 5 | $51,500 |
| MTST | MetaStat, Inc. | Director · lapsed | 2017-11-21 → 2017-11-21 | 1 | — |
| ALQA | Alliqua BioMedical, Inc. | Director · lapsed | 2015-11-09 → 2017-07-03 | 5 | $240,740 |
| AITB | AIT Therapeutics, Inc. | Director · lapsed | 2017-04-19 → 2017-04-19 | 1 | — |
| MTST.OB | MetaStat, Inc. | Director · lapsed | 2016-05-31 → 2017-04-06 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTCT | 2024-12-02 | Sell | 3,187 | $52.42 | $167,063 | 14,500 |
| PTCT | 2024-12-02 | Sell | 8,813 | $51.44 | $453,341 | 17,687 |
| PTCT | 2024-12-02 | Sell | 5,699 | $50.52 | $287,913 | 20,801 |
| PTCT | 2024-12-02 | Sell | 2,634 | $51.43 | $135,467 | 18,167 |
| PTCT | 2024-12-02 | Sell | 3,667 | $52.39 | $192,114 | 14,500 |
| NXGL | 2024-11-20 | Buy | 3,636 | $2.75 | $9,999 | 106,664 |
3 of 10 issuers are covered and open a security page; the rest are on file here only.
